Pfizer Takes Aim At Europe Over Prices

Pfizer (NYSE:PFE) has said that Europe is undermining drug innovation by cutting prices.

Pfizer Takes Aim At Europe Over Prices

According to a Reuters report, the US Based drug maker giant Pfizer (NYSE:PFE) chief said Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and “freeloading” off others in Asia and the U.S. who are willing to pay.

Ian Read, Chief executive of Pfizer (NYSE:PFE) said, “There is a disconnection in Europe between the marketplace for pharmaceuticals and the desire of European governments to have innovation and research. Governments in Europe that are becoming increasing reluctant to pay up for innovative therapies would eventually regret it.”

Pfizer Inc. (NYSE:PFE) company shares are currently standing at 22.01.

Price History
Last Price: 22.01
52 Week Low / High: 16.63 / 22.17
50 Day Moving Average: 21.48
6 Month Price Change %: 20.1%
12 Month Price Change %: 11.1%